Logo image of DCFC

TRITIUM DCFC LTD (DCFC) Stock Fundamental Analysis

NASDAQ:DCFC - Nasdaq - AU0000325136 - Common Stock - Currency: USD

3.64  +0.05 (+1.39%)

Premarket: 1.35 -2.29 (-62.91%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to DCFC. DCFC was compared to 93 industry peers in the Electrical Equipment industry. Both the profitability and financial health of DCFC have multiple concerns. DCFC is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year DCFC has reported negative net income.
In the past year DCFC has reported a negative cash flow from operations.
DCFC Yearly Net Income VS EBIT VS OCF VS FCFDCFC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -50M -100M -150M

1.2 Ratios

The Return On Assets of DCFC (-44.11%) is worse than 78.82% of its industry peers.
Industry RankSector Rank
ROA -44.11%
ROE N/A
ROIC N/A
ROA(3y)-58.9%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DCFC Yearly ROA, ROE, ROICDCFC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 200 -200 400 600 800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for DCFC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DCFC Yearly Profit, Operating, Gross MarginsDCFC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 -50 -100 -150

0

2. Health

2.1 Basic Checks

DCFC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DCFC has been increased compared to 1 year ago.
Compared to 1 year ago, DCFC has a worse debt to assets ratio.
DCFC Yearly Shares OutstandingDCFC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 50M 100M 150M
DCFC Yearly Total Debt VS Total AssetsDCFC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

DCFC has an Altman-Z score of -2.71. This is a bad value and indicates that DCFC is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.71, DCFC is doing worse than 81.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.71
ROIC/WACCN/A
WACC4.2%
DCFC Yearly LT Debt VS Equity VS FCFDCFC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 100M -100M

2.3 Liquidity

DCFC has a Current Ratio of 0.92. This is a bad value and indicates that DCFC is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.92, DCFC is doing worse than 91.76% of the companies in the same industry.
A Quick Ratio of 0.37 indicates that DCFC may have some problems paying its short term obligations.
DCFC has a worse Quick ratio (0.37) than 95.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.37
DCFC Yearly Current Assets VS Current LiabilitesDCFC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 50M 100M 150M 200M 250M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.77% over the past year.
Looking at the last year, DCFC shows a very strong growth in Revenue. The Revenue has grown by 115.03%.
The Revenue has been growing by 57.75% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)22.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.61%
Revenue 1Y (TTM)115.03%
Revenue growth 3Y57.75%
Revenue growth 5YN/A
Sales Q2Q%288.54%

3.2 Future

Based on estimates for the next years, DCFC will show a very strong growth in Earnings Per Share. The EPS will grow by 25.99% on average per year.
Based on estimates for the next years, DCFC will show a very strong growth in Revenue. The Revenue will grow by 49.26% on average per year.
EPS Next Y99.69%
EPS Next 2Y41.45%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year152.01%
Revenue Next 2Y121.82%
Revenue Next 3Y47.11%
Revenue Next 5Y49.26%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
DCFC Yearly Revenue VS EstimatesDCFC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
DCFC Yearly EPS VS EstimatesDCFC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -20 -40 -60 -80 -100

1

4. Valuation

4.1 Price/Earnings Ratio

DCFC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DCFC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DCFC Price Earnings VS Forward Price EarningsDCFC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DCFC Per share dataDCFC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 -100 200 -200

4.3 Compensation for Growth

DCFC's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.45%
EPS Next 3Y25.99%

0

5. Dividend

5.1 Amount

DCFC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TRITIUM DCFC LTD

NASDAQ:DCFC (4/17/2024, 8:00:01 PM)

Premarket: 1.35 -2.29 (-62.91%)

3.64

+0.05 (+1.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)03-07 2024-03-07/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.09M
Analysts80
Price Target1264.8 (34647.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)20117.5%
PT rev (3m)25467%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)9.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)26.63%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.78
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-200.52
FCFYN/A
OCF(TTM)-191.09
OCFYN/A
SpS217.06
BVpS-168.94
TBVpS-168.94
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.11%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-58.9%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 329.63%
Cap/Sales 4.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.37
Altman-Z -2.71
F-Score2
WACC4.2%
ROIC/WACCN/A
Cap/Depr(3y)253.33%
Cap/Depr(5y)N/A
Cap/Sales(3y)5.7%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.61%
EPS Next Y99.69%
EPS Next 2Y41.45%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)115.03%
Revenue growth 3Y57.75%
Revenue growth 5YN/A
Sales Q2Q%288.54%
Revenue Next Year152.01%
Revenue Next 2Y121.82%
Revenue Next 3Y47.11%
Revenue Next 5Y49.26%
EBIT growth 1Y-9.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year86.18%
EBIT Next 3Y34.44%
EBIT Next 5YN/A
FCF growth 1Y-81.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-87.05%
OCF growth 3YN/A
OCF growth 5YN/A